Measuring rates of brain atrophy from serial magnetic resonance imaging (MRI) scans is gaining acceptance as a valid noninvasive biomarker of disease progression in neurodegenerative conditions. To date, the two most widely used measurement techniques are, manual segmentation of specific structures (e.g. hippocampus), or semi-automated image registration and subtraction to generate whole brain atrophy rates. Both of these techniques, while useful, have important limitations in neurodegenerative conditions that are characterized by atrophy of select regions of the brain. A prototypical neurodegenerative condition that is characterized by selective atrophy is frontal temporal dementia (FTD). A class of computational techniques that we refer to in this application as tensor based morphometry (TBM) seem ideally suited to measure atrophy rates of defined regions/lobes of the brain from serial MRI scans. We have developed a prototype version of a TBM algorithm and the associated software code, but have not yet performed the clinical comparison studies necessary for validation. Another largely ignored but important technical topic addressed in this application is rigorous evaluation of sources of and methods to correct geometric distortion in MR images. This project has two major goals. The first is to optimize our prototype TBM method and to compare it to other approaches for validation purposes. We will also evaluate methods for correcting geometric distortion in MRI. This validation and testing work is the objective of Aims 1 and 2. The second major goal is to prospectively test the hypothesis that the regional atrophy rate measurement method developed during the technical phase of the project will provide group specific signatures that are characteristic of particular clinical phenotypes, specifically normal aging, AD, and FTD. We will test the hypothesis that TBM regional atrophy rate measures show greater clinical group specificity that global atrophy rate measures. We will also include pathological verification and correlation when possible.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG016574-08
Application #
7256283
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
8
Fiscal Year
2006
Total Cost
$176,240
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Vassilaki, Maria; Aakre, Jeremiah A; Syrjanen, Jeremy A et al. (2018) Mediterranean Diet, Its Components, and Amyloid Imaging Biomarkers. J Alzheimers Dis 64:281-290
Zhao, Na; Liu, Chia-Chen; Van Ingelgom, Alexandra J et al. (2018) APOE ?2 is associated with increased tau pathology in primary tauopathy. Nat Commun 9:4388
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Mordes, Daniel A; Prudencio, Mercedes; Goodman, Lindsey D et al. (2018) Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients. Acta Neuropathol Commun 6:55
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Zhan, Yiqiang; Clements, Mark S; Roberts, Rosebud O et al. (2018) Association of telomere length with general cognitive trajectories: a meta-analysis of four prospective cohort studies. Neurobiol Aging 69:111-116
Lowe, Val J; Bruinsma, Tyler J; Min, Hoon-Ki et al. (2018) Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants. Alzheimers Dement (Amst) 10:210-216
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Sassi, Celeste; Nalls, Michael A; Ridge, Perry G et al. (2018) Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3. Neurobiol Aging 66:179.e17-179.e29
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021

Showing the most recent 10 out of 1014 publications